Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "Benefits"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
dewey-ones:"330 - Economics"
language:"English"
Showing
141
-
160
of
231
Search:
'"Benefits"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
141
Pharmacoeconomic review report: Letermovir (Prevymis) (Merck Canada Inc.)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
142
CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
143
Pharmacoeconomic review report: Buprenorphine extended-release injection (Sublocade) (Indivior Canada, Ltd.) : indication, for the management of moderate-to-severe opioid use disor...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
144
Pharmacoeconomic review report: Vortioxetine hydrobromide (Trintellix) (Lundbeck Canada Inc.) : indication : the treatment of major depressive disorder in adults
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
145
Guanfacine hydrochloride extended-release for the treatment of attention deficit hyperactivity disorder in adults : a review of clinical effectiveness, cost-effectiveness, and guid...
by
Poitras, Veronica
,
McCormack, Suzanne
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
146
CADTH Canadian drug expert committee recommendation: Latanoprost (Monoprost -- Laboratoires Thea) : indication : glaucoma and ocular hypertension
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
147
Pharmacoeconomic review report: Letermovir (Prevymis) (Merck Canada Inc.)
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
148
Pharmacoeconomic review report: Iron isomaltoside 1000 (Monoferric) (Pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult patients who have intolera...
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
149
Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication: for the treatment of adult patients with active ankylosing spondylitis who have responded i...
Published 2020
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
150
CADTH Canadian drug expert committee recommendation (final): Certolizumab pegol (Cimzia -- UCB Canada Inc.) : indication : treatment of adult patients with moderate-to severe plaqu...
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
151
Pharmacoeconomic review report: Eliglustat (Cerdelga) : (Sanofi Genzyme) : indication: Gaucher disease type 1
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
152
Home transcutaneous electrical nerve stimulation for chronic pain : a review of the clinical effectiveness
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
153
High dose influenza vaccine for adults : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Wells, Charlotte
,
Grobelna, Aleksandra
Published 2019
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
154
Telehealth-delivered opioid agonist therapy for the treatment of adults with opioid use disorder : review of clinical effectiveness, cost-effectiveness, and guidelines
by
Ho, Chuong
,
Argáez, Charlene
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
155
Curosurf (poractant alfa) for the treatment of infants at risk for or experiencing respiratory distress syndrome : a review of clinical effectiveness, cost-effectiveness, and guide...
by
Chao, Yi-Sheng
,
Grobelna, Aleksandra
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
156
Pharmacoeconomic review report: Emtricitabine/tenofovir alafenamide (Descovy)
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
157
Pharmacoeconomic review report: Lumacaftor/Ivacaftor (Orkambi) (Vertex pharmaceuticals (Canada) Incorporated) : indication, for the treatment of cystic fibrosis in patients 6 years...
Published 2018
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
158
Methoxyflurane for acute pain in the emergency department : a review of clinical effectiveness, cost-effectiveness and guidelines
by
Wells, Charlotte
,
Adcock, Lorna
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
159
Bowel preparation for elective colorectal procedures : a review of clinical effectiveness, cost-effectiveness, and guidelines
by
Khangura, Sara
,
La Fleur, Philip
,
Argáez, Charlene
,
Adcock, Lorna
Published 2018
CADTH
Subjects:
“
...Cost-
Benefit
Analysis...
”
Read Now
160
CADTH Canadian Drug Expert Committee recommendation: Lixisenatide (Adlyxine -- Sanofi-Aventis Canada inc.) : indication : diabetes mellitus, type 2
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Cost-
Benefit
Analysis...
”
2
3
4
5
6
7
8
9
10
11
12
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Clear Filter
Classification: 330 - Economics
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
330 - Economics
610 - Medicine & health
76
140 - Specific philosophical schools
19
700 - The arts; fine & decorative arts
17
580 - Plants (Botany)
3
600 - Technology
2
more ...
615 - Pharmacology & therapeutics
2
100 - Philosophy & psychology
1
363 - Other social problems & services
1
800 - Literature & rhetoric
1
see all ...
less ...
Language
English
Collection
National Center for Biotechnology Information
231
Author
Canadian Agency for Drugs and Technologies in Health
CADTH Canadian Drug Expert Committee
50
Canadian Agency for Drugs and Technologies in Health Rapid Response Service
27
Adcock, Lorna
7
Ho, Chuong
7
Ford, Caitlyn
6
more ...
Grobelna, Aleksandra
5
Argáez, Charlene
4
Chao, Yi-Sheng
4
Gray, Casey
4
McCormack, Suzanne
4
Tran, Khai
4
Banerjee, Srabani
3
Campbell, Kaitryn
3
Loshak, Hannah
3
MacDougall, Danielle
3
Wells, Charlotte
3
Williams, D.
3
Young, Calvin
3
Farrah, Kelly
2
Frey, Nina
2
Jahagirdar, Deepa
2
Kanga, Ismat
2
Poitras, Veronica
2
Visintini, Sarah
2
Adams, Alison
1
Chiu, Stephanie
1
Cowling, Tara
1
De Nanassy, Alina
1
Edge, Rob
1
Harricharan, Sharada
1
Khangura, Sara
1
Klarenbach, Scott
1
Krahn, Murray
1
La Fleur, Philip
1
Lachance, Chantelle
1
Lee, Karen M.
1
Marchand, Dave K.
1
Membe, Stephen K.
1
Narain, Tasha
1
Palylyk-Colwell, Eugenia
1
Picheca, Lory
1
Singh, Sumeet
1
Spry, Carolyn
1
Thompson, Wade
1
Wong, William
1
Wright, Mary-Doug
1
Yeung, Shirley S. T.
1
see all ...
less ...
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?page=8&filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&filter%5B%5D=dewey-ones%3A%22330+-+Economics%22&filter%5B%5D=language%3A%22English%22&lookfor=%22Benefits%22&type=Subject
Send by Email
×
Loading...